NKTR - nektar.com Bozor qiymatining balans qiymatiga nisbati
Nektar Therapeutics (NKTR) zamonaviy AQSh tadqiqot va ishlanmalar (R&D) markazlariga tayanadi va dori-darmonlarni ommaviy ishlab chiqarishni sertifikatlangan uchinchi tomon pudratchilariga topshiradi. GURU.Markets platformasidagi ushbu narxlar grafigi hozirda 1.47 darajasida. Sun'iy intellekt va robototexnika tizimlarining joriy etilishi yangi molekulalarni kashf etishni tezlashtirmoqda, garchi yakuniy sinovlar insonlarning mas'uliyatida qolgan bo'lsa-da. Biotexnologiya laboratoriyalari sintez liniyalarining muntazam modernizatsiyasi tufayli uskunalarning eskirishilarsiz faoliyat yuritmoqda.
Nektar Therapeutics Inc (NKTR) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- bozor kapitallashuvi statistikasi:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Nektar Therapeutics|NKTR - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Nektar|NKTR - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Nektar|NKTR - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Nektar Therapeutics|Tezkor likvidlik koeffitsiyenti nektar.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Nektar Therapeutics - NKTR
Nektar Therapeutics (NKTR) kompaniyasining hamkorlikka asoslangan ishlanmalar modeli va mustahkam balans hisoboti bilan qo'llab-quvvatlanadigan immuno-onkologiya platformasining barqarorligi bozor tebranishlari paytidagi xatarlarni minimallashtiradi. Narxning buki ko'rsatkichini (price-to-book ratio) tahlil qilish orqali investor sof aktivlardan yuqori bo'lgan bozor premiumini baholaydi, bunda birlikdan chetlashish biznesning uning ichki qiymatiga nisbatan haddan tashqari yuqori yoki past baholanganligidan dalolat beradi.
Raqobatchilar tahlili
argenx SE (ARGX) - Bozor qiymatining balans qiymatiga nisbati|biontech.de - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati abivax.com|ADMA Biologics Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati PTGX|IMVT (Immunovant Therapeutics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|Bozor kapitallashuvining balans qiymatiga nisbati grifols.com GRFS|ADPT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com|Kapitallashuvning sof aktivlarga nisbati PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TRML (Tourmaline Corp)|Balans qiymatiga nisbatan bozor kapitallashuvi Precigen Corp (PGEN)|PHAR - Bozor qiymatining balans qiymatiga nisbati|upstreambio.com (UPB) - Kapitallashuvning sof aktivlarga nisbati|Zenas Biopharma (ZBIO) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Immunome Inc|Kapitallashuvning sof aktivlarga nisbati GOSS|Bozor kapitallashuvining balans qiymatiga nisbati KalVista Corp|Bozor qiymatining balans qiymatiga nisbati Septerna Inc (SEPN)|pieris.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati SVRA (Savara)|Rigel Pharma (RIGL) - Bozor qiymatining balans qiymatiga koeffitsiyenti|ANAB - Bozor qiymatining balans qiymatiga nisbati|ATXS (Astria Corp) - Kapitallashuvning balans qiymatiga nisbati|ENGN: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti rapt.com (RAPT)|Bozor qiymatining balans qiymatiga nisbati Aerovate Therapeutics, Inc.|Bozor kapitallashuvining balans qiymatiga nisbati Aclaris Therapeutics Inc.|Kapitallashuvning sof aktivlarga nisbati KYTX (Kyverna)|Bozor kapitallashuvining balans qiymatiga multiplikatori TLSA|Bozor kapitallashuvining balans qiymatiga nisbati CABA (Cabaletta Bio, Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati ventyxbio.com VTYX|THTX - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati AVTX (Avalo Therapeutics, Inc.)|ELDN (Eledon) - Kapitallashuvning sof aktivlarga nisbati|Agenus, Inc - Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati CLYM|ZURA (zurabio.com) - Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor kapitallashuvining balans qiymatiga nisbati ATYR|ADAG (adagene.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati IMA (Ikena Oncology)|Shattuck Labs Inc (STTK) - Bozor qiymatining balans qiymatiga koeffitsiyenti|EQ - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CNTB (Connect Biopharma)|IMUX: Bozor kapitallashuvining balans qiymatiga nisbati|Atara Bio (ATRA) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati InflaRx NV|X4 Pharmaceuticals, Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati ACET|CELU - Bozor qiymatining balans qiymatiga koeffitsiyenti|INmune Bio - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Barinthus Biotherapeutics PLC BRNS|KZR: Kapitallashuvning sof aktivlarga nisbati|SAB Biotherapeutics Inc - Bozor kapitallashuvining balans qiymatiga multiplikatori|AKTX: Bozor kapitallashuvining balans qiymatiga nisbati|ENLV - Balans qiymatiga nisbatan bozor kapitallashuvi|QTTB (Q32 Bio Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati GeoVax Labs (GOVX)|Bozor qiymatining balans qiymatiga nisbati Edesa (EDSA)|Balans qiymatiga nisbatan bozor kapitallashuvi iBio Corporation|Bozor qiymatining balans qiymatiga nisbati Carisma Therapeutics Inc. CARM|XTLB: Kapitallashuvning balans qiymatiga nisbati|BOLT - Bozor qiymatining balans qiymatiga nisbati|HCWB - Bozor kapitallashuvining balans qiymatiga nisbati|APVO (aptevotherapeutics.com) - Kapitallashuvning sof aktivlarga nisbati|AIM: Bozor kapitallashuvining balans qiymatiga multiplikatori|Bozor qiymatining balans qiymatiga nisbati Aditxt Inc.|GRI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati XORTX Therapeutics (XRTX)|HIND: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati REVB (Revelation Bio)|Balans qiymatiga nisbatan bozor qiymati INDP|Scinai Immunotherapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|CALI - Bozor kapitallashuvining balans qiymatiga nisbati|affimed.com (AFMD) - Bozor qiymatining balans qiymatiga nisbati|Allakos - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati HOOKIPA Pharma, Inc.|Kapitallashuvning sof aktivlarga nisbati IGM Bio (IGMS)|Bozor kapitallashuvining balans qiymatiga nisbati ITOS|Bozor kapitallashuvining balans qiymatiga nisbati oceanbiomedical.com (OCEA)|TC BioPharm - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati THRD